CDC Issues Updated Postexposure Guidelines for HBV, HCV, and HIV

Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis.

This report updates and consolidates all previous U.S. Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that might contain hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV). Recommendations for HBV postexposure management include initiation of the hepatitis ...

CDC grants 'equivalency' to 22 state guidelines for management of HIV- and HBV-infected healthcare workers.

Updated CDC guidelines for HIV testing: a review for Wisconsin practitioners.

An estimated 250,000 people in the United States are living with undiagnosed human immunodeficiency virus (HIV) infection. Those who are unaware they are HIV-infected miss opportunities for early treatment and may unknowingly infect others. Early identification of HIV-infected individuals benefits both the infected individuals and the health of the public. To decrease the number of individuals ...

Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis.

This report updates U.S. Public Health Service recommendations for the management of health-care personnel (HCP) who have occupational exposure to blood and other body fluids that might contain human immunodeficiency virus (HIV). Although the principles of exposure management remain unchanged, recommended HIV postexposure prophylaxis (PEP) regimens have been changed. This report emphasizes adhe...

HIV and HCV Coinfection 541 18. HIV and HBV/HCV Coinfections

As HCV is ten times more infectious than HIV on blood-to-blood contact, intravenous drug users and recipients of blood products are particularly susceptible to coinfection. For example, on routine testing of blood products from HIV-infected hemophiliacs treated before the discovery of HCV in the early nineties, HCV antibodies and HCV RNA were detected in the serum of over 90 % of patients. The ...